Market Overview:
The global closed vial access devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. Closed vial access devices are medical devices that allow for the withdrawal or introduction of fluids into a sealed container, such as a vial or syringe, without breaking the seal. These devices are used in various applications such as hospital and clinic settings. The increasing demand for minimally invasive procedures and rising number of cancer patients are some of the major factors driving the growth of this market. Additionally, technological advancements in closed vial access devices are also contributing to its growth.
Product Definition:
A closed vial access device is a medical device designed to allow the introduction of a needle or other instrument into a sealed vial for the withdrawal or introduction of fluid without breaking the seal. Closed vial access devices are often used to transfer medication from one container to another, or to measure and withdraw fluid from a sealed container. Closed vial access devices are important because they allow for safe and controlled handling of fluids in sealed containers.
With Needle:
With Needle, it's usage and growth factor in the Closed Vial Access Devices market is used for the administration of drugs or fluids into a patient’s body. It’s major applications are in chemotherapy, anaphylaxis management, insulin delivery (in diabetes), and vaccine administration. With needle it's also called as “IV needle” or “syringe”.
Needleless:
Needleless is a technology that uses a needle-free injection system to inject medication. It's major advantage is that there are no need for any sharp needles, thus reducing the risk of injuries associated with it. Needleless can be used in various applications such as parenteral nutrition, intravenous infusion set up and drug delivery devices among others.
The global needleless.
Application Insights:
Based on the application, the global closed vial access devices market has been segmented into hospital and clinic. The hospital segment dominated the overall market in terms of revenue in 2017 due to a large number of procedures involving IVF that require IV fluid administration. Moreover, increasing R&D activities for developing advanced products for use at hospitals is further expected to drive growth over the forecast period.
Clinical trials are an important part of medical research. They involve giving investigational drugs or treatments to selected patients so that they can give feedback about it before giving it to a larger population.
Regional Analysis:
North America dominated the global closed vial access devices market in 2017. This can be attributed to factors such as increasing incidence of cancer, rising preference for minimally invasive surgeries, and growing adoption of advanced technology in healthcare. Moreover, high prevalence of chronic diseases and favorable reimbursement policies are also expected to drive the regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rapidly improving healthcare infrastructure coupled with increasing demand for advanced medical products in this region. In addition, economic development coupled with government initiatives aimed at reducing disease burden is further expected fuel CAGR during the estimated time frame.
Growth Factors:
- Increasing demand for minimally invasive surgeries: Closed Vial Access Devices offer a number of advantages over traditional open surgery, including reduced surgical time, less blood loss and trauma, and faster patient recovery. This is driving the adoption of closed vial access devices in hospitals worldwide.
- Growing use of disposable devices: Closed Vial Access Devices are increasingly being used as disposable devices due to their ease of use and low cost of ownership. This is helping to drive the growth of the market.
- Rising demand for single-use products: Closed Vial Access Devices are predominantly single-use products, which helps reduce the risk of cross contamination between patients. This is another factor contributing to the growing popularity of these devices among healthcare providers worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Closed Vial Access Devices Market Research Report
By Type
With Needle, Needleless
By Application
Hospital, Clinic
By Companies
Becton Dickinson, TELEMED, ICU Medical, Teva Medical, Corvida Medical, B. Braun, Needleless, Becton Dickinson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
136
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Closed Vial Access Devices Market Report Segments:
The global Closed Vial Access Devices market is segmented on the basis of:
Types
With Needle, Needleless
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton Dickinson
- TELEMED
- ICU Medical
- Teva Medical
- Corvida Medical
- B. Braun
- Needleless
- Becton Dickinson
Highlights of The Closed Vial Access Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- With Needle
- Needleless
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Closed Vial Access Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Closed Vial Access Devices (CVADs) are medical devices that allow for the safe and controlled delivery of medications or other treatments directly to a patient's bloodstream. CVADs can be used in a variety of settings, including hospitals, clinics, and doctor's offices.
Some of the major players in the closed vial access devices market are Becton Dickinson, TELEMED, ICU Medical, Teva Medical, Corvida Medical, B. Braun, Needleless, Becton Dickinson.
The closed vial access devices market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Closed Vial Access Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Closed Vial Access Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Closed Vial Access Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Closed Vial Access Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Closed Vial Access Devices Market Size & Forecast, 2018-2028
4.5.1 Closed Vial Access Devices Market Size and Y-o-Y Growth
4.5.2 Closed Vial Access Devices Market Absolute $ Opportunity
Chapter 5 Global Closed Vial Access Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Closed Vial Access Devices Market Size Forecast by Type
5.2.1 With Needle
5.2.2 Needleless
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Closed Vial Access Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Closed Vial Access Devices Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Closed Vial Access Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Closed Vial Access Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Closed Vial Access Devices Analysis and Forecast
9.1 Introduction
9.2 North America Closed Vial Access Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Closed Vial Access Devices Market Size Forecast by Type
9.6.1 With Needle
9.6.2 Needleless
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Closed Vial Access Devices Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Closed Vial Access Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Closed Vial Access Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Closed Vial Access Devices Market Size Forecast by Type
10.6.1 With Needle
10.6.2 Needleless
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Closed Vial Access Devices Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Closed Vial Access Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Closed Vial Access Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Closed Vial Access Devices Market Size Forecast by Type
11.6.1 With Needle
11.6.2 Needleless
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Closed Vial Access Devices Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Closed Vial Access Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Closed Vial Access Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Closed Vial Access Devices Market Size Forecast by Type
12.6.1 With Needle
12.6.2 Needleless
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Closed Vial Access Devices Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Closed Vial Access Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Closed Vial Access Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Closed Vial Access Devices Market Size Forecast by Type
13.6.1 With Needle
13.6.2 Needleless
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Closed Vial Access Devices Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Closed Vial Access Devices Market: Competitive Dashboard
14.2 Global Closed Vial Access Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton Dickinson
14.3.2 TELEMED
14.3.3 ICU Medical
14.3.4 Teva Medical
14.3.5 Corvida Medical
14.3.6 B. Braun
14.3.7 Needleless
14.3.8 Becton Dickinson
